The vaccine of Pfizer-BioNTech for the coronavirus disease 2019 (Covid-19) has a good chance of securing an emergency use authorization (EUA) in the Philippines, according to the country’s Food and Drug Administration (FDA).
“Maganda po ang kaniyang chance na magkaroon din ng EUA dito kung mag-apply siya. Unang-una, ‘yun pong counterpart ng FDA sa United Kingdom ay itinuturing natin na isang stringent regulatory authority ‘yan. Alam po nating sinuri nila nang husto ang mga datos (Pfizer-BioNTech has a good change to get an EUA if they apply. Firstly, the counterpart of the Philippine FDA in the United Kingdom we can consider as a stringent regulatory authority. We know they (UK FDA) studies carefully relevant data),” FDA Director-General Eric Domingo said in an online interview on Thursday.
But he said the Philippine FDA will still ask for the important prerequisites from Pfizer-BioNTech such as information on the “stability” of their product if it will be shipped to the country, since the country has a tropical climate and their vaccine has cold-storage requirements.
On Wednesday, the UK approved for use the Covid-19 vaccine of Pfizer-BioNTech, and roll out of the first stocks is expected next week.
President Rodrigo Duterte issued on Monday an executive order shortening the period to get regularity approval for candidate Covid-19 vaccines from the usual six months to 30 days or less. SOVEREIGNPH